Aptorum Group Enters Into Material Transfer and Exclusive Option-To-License Agreement with Yale University for Its Novel Immunomodulators Potentially Targeting Autoimmune and Oncology Diseases
Stock Information for Aptorum Group Limited
Loading
Please wait while we load your information from QuoteMedia.